New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
15:32 EDTVASCVascular Solutions to pay $520K to resolve false claims charges
Vascular Solutions has agreed to pay $520,000 to resolve allegations that it caused false claims to be submitted to federal health programs by marketing a medical device for the ablation of perforator veins without FDA approval and despite the failure of its own clinical trial, the Justice Department announced. The allegations resolved by the settlement were raised in a lawsuit filed against VSI by DeSalle Bui, a former sales representative at VSI, under the qui tam, or whistleblower, provisions of the False Claims Act, which allow private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery.
News For VASC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2015
07:41 EDTVASCVascular Solutions an underappreciated growth story, says Canaccord
Subscribe for More Information
April 21, 2015
16:21 EDTVASCVascular Solutions sees Q2 adjusted EPS 25c-27c, consensus 23c
Subscribe for More Information
16:20 EDTVASCVascular Solutions raises FY15 adjusted EPS to 93c-97c, consensus 89c
Subscribe for More Information
16:19 EDTVASCVascular Solutions reports Q1 adjusted EPS 21c, consensus 18c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use